Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Fechter

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Scientific Reports|October 30, 2024
A student trained convolutional neural network competing with a commercial AI software and experts in organ at risk segmentationSophia L Bürkle, Dejan Kuhn, Tobias Fechter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 24, 2015
MRI versus ⁶⁸Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancerConstantinos Zamboglou, Gesche Wieser, Steffen Hennies, et al.
Cancers|March 6, 2021
FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation TherapyMontserrat Carles, Tobias Fechter, Gianluca Radicioni, et al.
Physics and Imaging in Radiation Oncology|April 10, 2026
Periodic intrafraction image-guided focal dose-escalated stereotactic body radiotherapy for prostate carcinoma on a standard linear acceleratorMarco Serpa, Rolf Wiehle, Thomas Rothe, et al.
Cancers|July 24, 2021
<sup>18</sup>F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-RadiotherapyMontserrat Carles, Tobias Fechter, Anca L Grosu, et al.
Theranostics|May 28, 2019
Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology referenceConstantinos Zamboglou, Montserrat Carles, Tobias Fechter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 17, 2025
Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]PSMA-1007Philipp Moritz Adrian Waibel, Ievgen Glavynskyi, Tobias Fechter, et al.
Radiation Oncology (London, England)|August 7, 2024
The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on <sup>18</sup>F-PSMA-1007 PETJulius C Holzschuh, Michael Mix, Martin T Freitag, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 2, 2023
Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancerJulius C Holzschuh, Michael Mix, Juri Ruf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of referenceConstantinos Zamboglou, Thomas F Fassbender, Lina Steffan, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Scientific Reports|October 30, 2024
A student trained convolutional neural network competing with a commercial AI software and experts in organ at risk segmentationSophia L Bürkle, Dejan Kuhn, Tobias Fechter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 24, 2015
MRI versus ⁶⁸Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancerConstantinos Zamboglou, Gesche Wieser, Steffen Hennies, et al.
Cancers|March 6, 2021
FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation TherapyMontserrat Carles, Tobias Fechter, Gianluca Radicioni, et al.
Physics and Imaging in Radiation Oncology|April 10, 2026
Periodic intrafraction image-guided focal dose-escalated stereotactic body radiotherapy for prostate carcinoma on a standard linear acceleratorMarco Serpa, Rolf Wiehle, Thomas Rothe, et al.
Cancers|July 24, 2021
<sup>18</sup>F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-RadiotherapyMontserrat Carles, Tobias Fechter, Anca L Grosu, et al.
Theranostics|May 28, 2019
Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology referenceConstantinos Zamboglou, Montserrat Carles, Tobias Fechter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 17, 2025
Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]PSMA-1007Philipp Moritz Adrian Waibel, Ievgen Glavynskyi, Tobias Fechter, et al.
Radiation Oncology (London, England)|August 7, 2024
The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on <sup>18</sup>F-PSMA-1007 PETJulius C Holzschuh, Michael Mix, Martin T Freitag, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 2, 2023
Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancerJulius C Holzschuh, Michael Mix, Juri Ruf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of referenceConstantinos Zamboglou, Thomas F Fassbender, Lina Steffan, et al.
Pageof 4